This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Interdict Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lawrence Hamann and Small-Molecule Protein Synthesis Modulators.
Introduction
Lawrence Hamann is an inventor based in San Francisco, California, and is associated with Interdict Bio, Inc. His work includes a patent application concerning compounds designed to modulate protein synthesis.
Latest Patents
Hamann is credited with 1 patent. His patent, “Small Molecule Protein Synthesis Modulators,” describes compounds and their pharmaceutically acceptable salts for modulating protein synthesis. It also covers pharmaceutical compositions and kits containing these compounds, as well as methods for treating or preventing diseases and disorders associated with targets such as BCL-2, MYC, CCND1, MCL-1, ALK, and KRAS-G12D.
Career Highlights
Hamann’s listed work is connected to Interdict Bio, Inc., a company focused on biotechnology. The patent disclosure reflects an approach to therapeutic research that seeks to influence protein synthesis and address diseases associated with specific molecular targets.
Collaborations
His listed coworkers include Sogole Sami Bahmanyar and Zef Konst. Their shared association with the company provides context for Hamann’s professional network.
Conclusion
Lawrence Hamann’s patent work at Interdict Bio, Inc. centers on small-molecule approaches to modulating protein synthesis, with potential applications in treating or preventing diseases linked to several molecular targets.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile